Semasize 0.25mg 0.5 Injection Semaglutide (1 Multi-dose Disposable Pen, 6 Needle, 6 Alcohol Swab)
Semasize 0.25mg/0.5 Injection is a semaglutide injection used to manage type 2 diabetes and support weight loss. It helps control blood sugar, suppress appetite, and improves metabolic health when combined with diet and physical activity.
Product Overview
Semasize (Semaglutide) Injection is designed for the management of type 2 diabetes and chronic weight management. It contains Semaglutide, is an advanced glucagon-like peptide-1 (GLP-1) receptor agonist. This medication works by mimicking the natural hormones that regulate blood sugar levels and appetite. By enhancing insulin secretion in response to glucose and slowing gastric emptying, Semasize helps patients achieve better glycemic control and sustained weight loss. The multi-dose disposable pen is engineered for precision and ease of use, allowing for convenient subcutaneous administration once a week.
Product Composition
- Active Ingredient: Semaglutide
- Concentration: Available in strengths corresponding to 0.25 mg or 0.5 mg per dose.
- Excipients: Disodium phosphate dihydrate, propylene glycol, phenol, and water for injection.
- Packaging: 1 Multi-dose Disposable Pen, 6 Disposable Needles, and 6 Alcohol Swabs.
- Action Category: GLP-1 Receptor Agonist / Antidiabetic / Anti-obesity.
Product Specifications
| Feature | Description |
| Therapeutic Class | Incretin Mimetic |
| Route of Administration | Subcutaneous Injection |
| Dosing Frequency | Once Weekly |
| Delivery System | Pre-filled, Multi-dose Dial-a-dose Pen |
Mechanism of Action
- Glucose-Dependent Insulin Secretion: Stimulates the pancreas to release insulin only when blood sugar levels are high, reducing the risk of hypoglycemia.
- Glucagon Suppression: Lowers inappropriately high glucagon secretion, which prevents the liver from releasing excess sugar into the bloodstream.
- Gastric Emptying Delay: Slows the rate at which food leaves the stomach, leading to a more gradual absorption of nutrients and lower post-meal glucose spikes.
- Appetite Regulation: Acts on specific receptors in the brain to increase feelings of fullness (satiety) and decrease hunger signals, supporting long-term caloric reduction.
Key Benefits
- Significant Glycemic Control: Effectively lowers HbA1c levels, helping patients reach their target blood sugar ranges.
- Weight Management Support: Promotes clinically meaningful weight loss by reducing appetite and slowing digestion.
- Cardiovascular Protection: Clinical evidence suggests a reduction in the risk of major adverse cardiovascular events in patients with established heart disease.
- Convenient Weekly Dosing: The once-weekly schedule improves patient adherence compared to daily medications.
- Complete Kit: Includes all necessary accessories (needles and swabs) for a sterile and ready-to-use experience.
Precautions
General Precautions
| Aspect | Precaution |
|---|---|
| Medical Supervision | Use only under strict doctor guidance for proper dosing and monitoring |
| Thyroid Disorders | Avoid use in patients with history of thyroid tumors or related conditions |
| Pancreatitis Risk | Use cautiously in patients with history of pancreatitis |
| Kidney Function | Monitor kidney health, especially in patients with existing kidney issues |
| Pregnancy & Breastfeeding | Use only if clearly prescribed by a healthcare professional |
Key Safety Guidelines
- Follow prescribed dosage schedule and do not self-adjust dose
- Inject as instructed using proper technique and hygiene
- Rotate injection sites to avoid skin irritation
- Monitor blood sugar levels regularly during treatment
- Inform your doctor about all medications and medical conditions
- Avoid skipping doses or doubling doses without advice
- Store the injection as per recommended conditions
Important Note
- Discontinue use and seek medical help if severe abdominal pain or signs of pancreatitis occur
- Report symptoms like neck swelling or difficulty swallowing immediately
- Regular monitoring is essential for safe and effective diabetes management
Usage
Usage Guidelines
| Step | Instruction |
| Preparation | Check the solution in the pen; it should be clear and colorless. Clean the injection site with an alcohol swab. |
| Attachment | Take a new disposable needle and screw it straight and tightly onto the pen. |
| Priming | For the first use of a new pen, check the flow by dialing to the flow check symbol and pressing the button. |
| Selection | Turn the dose selector until the prescribed dose (0.25 mg or 0.5 mg) aligns with the dose pointer. |
| Injection | Insert the needle into the skin of the abdomen, thigh, or upper arm; press and hold the button until the counter returns to 0. |
| Completion | Keep the needle in the skin for at least 6 seconds after the counter hits 0, then remove and safely discard the needle. |
Dosage & Administration
Semasize must be administered according to a strict schedule to ensure tolerance and efficacy:
Administer the injection once weekly, on the same day each week, at any time of day.
The dose can be taken with or without meals.
Initiate treatment with a starting dose of 0.25 mg once weekly for the first 4 weeks to allow the body to adjust.
After 4 weeks, the dose is typically increased to 0.5 mg once weekly.
Rotate the injection site with each dose to reduce the risk of skin irritation or lumps; do not use the exact same spot every time.
If a dose is missed, it should be administered within 5 days of the missed dose; if more than 5 days have passed, skip the missed dose and resume on the next regularly scheduled day.
Store the pen in the refrigerator ($2^{\circ}C$ to $8^{\circ}C$) before first use; after the first use, the pen can be kept at room temperature or in the refrigerator for up to 56 days.
Uses
Type 2 Diabetes Management: Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Chronic Weight Management: Used for long-term weight reduction in individuals with a high Body Mass Index (BMI) or weight-related medical conditions.
Cardiovascular Risk Reduction: Helps lower the risk of major cardiovascular events such as heart attack or stroke in patients with type 2 diabetes and established heart disease.
HbA1c Reduction: Effectively lowers long-term blood sugar markers to help prevent diabetic complications.
Side effects
Common Side Effects
- Nausea or vomiting
- Diarrhea or constipation
- Decreased appetite
- Abdominal discomfort or bloating
Less Common Side Effects
- Indigestion or acid reflux
- Fatigue or weakness
- Dizziness
- Mild injection site reactions such as redness or itching
Rare Side Effects
| Rare Side Effect | Description |
|---|---|
| Pancreatitis | Severe abdominal pain that may radiate to the back requiring immediate medical attention |
| Thyroid Tumors | Rare risk of thyroid gland abnormalities including swelling or lumps |
| Severe Hypoglycemia | Very low blood sugar especially when used with other antidiabetic drugs |
| Kidney Function Changes | Worsening kidney function in susceptible individuals |
| Severe Allergic Reaction | Rash, swelling, or difficulty breathing requiring urgent care |
Safety Note
- Seek immediate medical attention if symptoms of pancreatitis or severe allergic reaction occur
- Monitor blood sugar levels regularly during treatment
- Consult your doctor if side effects persist or worsen
- Use only under medical supervision for safe and effective results
FAQs
| Manufacturer | : | Alkem Laboratories Ltd |
| Trade Name | : | Ozempic |
| Generic Search | : | Semaglutide |
| Strength | : | 0.25mg/0.5 mg |
Certified Content
Dr. Priya Nair
Clinical Pharmacist & Senior Drug Information Specialist | 9 years
Pharm.D. (Doctor of Pharmacy)
Latest Products
